The same substance that hampers the infection capability of bacteria can hasten the fiber formation of the protein that is involved in the development of Parkinson’s disease. The study shows how important basic research is to our understanding of possible side effects from drug candidates interacting with various target proteins.

The research is being conducted at the Chemical Biology Centre, KBC, and the Umeå Centre for Microbial Research, UCMR at Umeå University and is based on the combined expertise of the chemists Pernilla Wittung-Stafshede, Magnus Wolf-Watz, and Fredrik Almqvist.

Read the press release from Umeå University